Literature DB >> 30455417

Clinicopathologic and genetic characteristics of interval colorectal carcinomas favor origin from missed or incompletely excised precursors.

Thing Rinda Soong1, Jennifer Nayor2, Matthew D Stachler1, Molly Perencevich3, Kunal Jajoo3, John R Saltzman2, Neal I Lindeman1, Amitabh Srivastava4.   

Abstract

Interval colorectal cancers may arise from missed or incompletely excised precursors or from a unique rapid progression pathway. We compared the clinicopathologic and molecular profiles of interval and matched non-interval colorectal cancer to determine whether interval colorectal cancers harbor any unique genetic characteristics. Fifty one of 982 colorectal cancer (5.2%) were categorized as interval colorectal cancer, defined as colorectal cancer detected in a diagnostic examination prior to the next recommended colonoscopy and at least 1 year after the last colonoscopy. Clinicopathologic characteristics of interval colorectal cancer were compared to non-interval colorectal cancer matched 1:1 on age, gender, and tumor location. Molecular profile of a subset of interval colorectal cancer (n = 20) and matched (1:2) non-interval colorectal cancer (n = 40) were evaluated using next generation sequencing. Interval colorectal cancer were more likely to occur in the right colon (55% vs. 35%; p = 0.02) and in patients > 70 years of age (55% vs. 34%; p = 0.002). Clinicopathologic features and aberrant DNA mismatch repair protein expression were not significantly different between interval and matched non-interval colorectal cancer. The frequency and spectrum of genetic alterations was also similar in interval and matched non-interval colorectal cancer. Similar findings were seen when analysis was restricted to interval colorectal cancer diagnosed <5 years after last colonoscopy (n = 42). Interval and non-interval colorectal cancers share similar clinicopathologic and genetic profiles when matched for tumor location. Interval colorectal cancers and are more likely to develop from missed or incompletely excised precursors rather than a unique rapid progression pathway.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30455417     DOI: 10.1038/s41379-018-0176-6

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  4 in total

1.  Atypical Presentation of Interval Colorectal Cancer/Post-Colonoscopy Colorectal Cancer in a Nursing Home Patient.

Authors:  Medha R Cherabuddi; Nithin Kurra; Saivishnu Doosetty; Nikhila Gandrakota
Journal:  Cureus       Date:  2022-05-09

2.  Clinically significant serrated polyp detection rates and risk for postcolonoscopy colorectal cancer: data from the New Hampshire Colonoscopy Registry.

Authors:  Joseph C Anderson; William Hisey; Todd A Mackenzie; Christina M Robinson; Amitabh Srivastava; Reinier G S Meester; Lynn F Butterly
Journal:  Gastrointest Endosc       Date:  2022-03-08       Impact factor: 10.396

3.  Endoscopically Injectable Shear-Thinning Hydrogels Facilitating Polyp Removal.

Authors:  Yan Pang; Jinyao Liu; Zaina L Moussa; Joy E Collins; Shane McDonnell; Alison M Hayward; Kunal Jajoo; Robert Langer; Giovanni Traverso
Journal:  Adv Sci (Weinh)       Date:  2019-07-30       Impact factor: 16.806

4.  Post-colonoscopy colorectal cancers identified by probabilistic and deterministic linkage: results in an Australian prospective cohort.

Authors:  Kavitha Subramaniam; P W Ang; Teresa Neeman; Mitali Fadia; Doug Taupin
Journal:  BMJ Open       Date:  2019-06-21       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.